NCT03383887View on ClinicalTrials.gov

DAW1033D in Obstructive Sleep Apnea

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

December 13, 2017

Primary Completion Date

January 20, 2020

Study Completion Date

January 20, 2020

Conditions
Obstructive Sleep Apnea (OSA)
Interventions
DRUG

Placebo oral capsule

Placebo before sleep

DRUG

DAW1033D oral capsule

DAW1033D before sleep

Trial Locations (1)

02115

Sleep Disorders Research Program Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT03383887 - DAW1033D in Obstructive Sleep Apnea | Biotech Hunter | Biotech Hunter